Published by Dr. Brandon Richland, MD
Many people looking for a new way to lose weight have started hearing about oral semaglutide treatment. It is a medicine that was first used to help with diabetes, but now people are wondering if it can also help with weight loss. Yes, research shows that oral semaglutide can help some people lose weight by making them feel full longer and reducing their appetite.
Oral semaglutide has become an option for people who prefer pills instead of injections. Studies have shown that people taking oral semaglutide lost more weight compared to those not taking the medicine.
Oral semaglutide is a tablet that helps manage blood sugar and support weight loss. It contains a specific GLP-1 receptor agonist and offers an alternative to taking medicine through injections.
Oral semaglutide is made by Novo Nordisk and is taken as a pill once a day. It contains the same active ingredient as the injectable form but is available in a tablet instead of a shot. This makes it easier for people who do not want daily or weekly injections.
Both forms belong to a drug class called GLP-1 receptor agonists. These medicines help the body release insulin, slow digestion, lower appetite, and manage blood sugar. Compared to semaglutide injections, the tablet form of semaglutide can be more convenient and may fit better into some people’s routines.
There are some differences between the two types. The injectable version may be prescribed for people who need higher doses or faster results. Some studies show both forms work for weight loss, but individual results may vary. Side effects like nausea and digestive issues can occur with either form.
The U.S. Food and Drug Administration (FDA) approved oral semaglutide in September 2019 for use in adults with type 2 diabetes. The approval allowed its use alongside diet and exercise to improve blood sugar control. The medicine was developed by Novo Nordisk and is sold under the brand name Rybelsus.
As a GLP-1 agonist, the drug semaglutide was already used as an injection for diabetes and weight loss. The tablet form marked the first time this type of medicine could be taken orally. Higher oral semaglutide doses have been studied for weight loss in people without diabetes, expanding its potential uses.
Oral semaglutide’s development focused on making semaglutide easier to take for patients. The FDA required strong evidence for safety and effectiveness before the approval. Its introduction has given patients more options beyond injectable semaglutide and other GLP-1 drugs.
Oral semaglutide is a medicine used to support weight loss in people with or without diabetes. This drug works inside the body by targeting hormones and processes linked to appetite, digestion, and blood sugar.
Oral semaglutide belongs to a group of drugs called GLP-1 receptor agonists. This means it mimics the action of the GLP-1 hormone naturally made in the gut. When taken as a pill, semaglutide helps control hunger.
It slows down how quickly food leaves the stomach, making a person feel full for longer. As a result, people eat less, which can help with weight loss. This effect has been shown in studies, with people losing an average weight of 2.7 kg when taking oral semaglutide compared to placebo pills.
This medication also helps the pancreas release more insulin and less glucagon when blood sugar is high. Insulin lowers blood sugar, while glucagon raises it. By controlling both, semaglutide treatment helps keep blood sugar in a healthy range, supporting weight loss and better metabolic health.
The GLP-1 hormone (glucagon-like peptide-1) has a key role in appetite and digestion. After people eat, GLP-1 is released from the intestines. It sends signals to the brain to help people feel full.
Semaglutide acts like natural GLP-1. It strengthens these signals, so people get full faster during meals. Because of this, they do not need to eat as much food to feel satisfied.
GLP-1 also helps manage blood sugar by slowing how fast the stomach empties food and boosting insulin release after meals. At the same time, it tells the pancreas to make less glucagon, cutting down spikes in blood sugar.
These actions together can make it easier for people to lose weight while also improving blood sugar levels. The combined effect reduces overeating and helps the body use food more efficiently.
Oral semaglutide has been tested in large clinical trials, including the OASIS 1 and Phase 3a studies. Results show important changes in body weight and provide strong clinical proof of its effectiveness in people with overweight or obesity.
In the OASIS 1 trial, adults with overweight or obesity took oral semaglutide 50 mg once daily for 68 weeks. The trial reported an average weight loss of 15.1%. More than two-thirds of participants experienced noticeable drops in their body weight. These results are very similar to what was seen with injected semaglutide, showing that the oral form works well for weight management.
The Phase 3a PIONEER trials tested oral semaglutide’s impact on blood sugar and weight. Across these studies, oral semaglutide led to clear weight reduction. Patients taking the medicine also had improvements in heart health and blood sugar control, supporting its use for people struggling with both diabetes and obesity.
When compared to a placebo, the difference is easy to see. In placebo groups, weight loss was much smaller or did not happen at all. In OASIS 1, the average weight loss with oral semaglutide was 15.1%, while the placebo group had much less. More than half of the people taking the medication lost at least 15% of their body weight. By contrast, very few in the placebo group reached these results.
The studies measured primary endpoints like percent body weight lost and the proportion of people hitting certain weight loss targets. In the OASIS 1 trial, these endpoints were met and reached statistical significance. This means the weight loss seen was not due to chance.
The PIONEER studies used similar main endpoints. They consistently found larger and more frequent weight reduction with oral semaglutide versus placebo. These results confirm that oral semaglutide offers a reliable and scientifically proven benefit for weight loss. Researchers also looked at safety, which was similar to other drugs in this class, making oral semaglutide a strong choice for eligible patients.
Oral and injectable GLP-1 medications like semaglutide are available in different forms and doses. They share the same main ingredient but are approved for different uses and have unique pros and cons for weight loss.
Rybelsus is an oral semaglutide tablet, while Ozempic and Wegovy are injectable semaglutide medications. Both Ozempic and Wegovy are used as weekly injections, but only Wegovy is approved for weight loss. Ozempic is mainly for type 2 diabetes.
Rybelsus is not approved for weight loss, but studies show that it may help some people lose weight, just not as much as the injectables. Wegovy, in particular, leads to more weight loss than other GLP-1 agonists, including oral forms like Rybelsus. Wegovy treatment is usually prescribed at higher doses meant specifically for weight management.Â
Oral semaglutide gives patients an option to avoid needles, making it easier for those who don’t like shots. The active ingredient is the same, but the body may absorb less semaglutide from a pill compared to an injection.
This means patients might see better results with injectable semaglutide (like Wegovy or Ozempic) for both blood sugar control and weight loss. Semaglutide injections are also approved at higher doses for weight management. However, the oral version is still convenient, especially for those who cannot use injections. Some studies suggest oral semaglutide can lower blood sugar about as well as the injections, but injectables often show greater weight loss.
Oral semaglutide is used to support weight loss, blood sugar control, and may help those dealing with obesity and related health problems. Its effects are most noticeable in people seeking weight management or who have certain chronic health conditions.
People who have struggled to lose weight through diet and exercise alone may find oral semaglutide helpful. It is most often considered for adults with a body mass index (BMI) of 30 or higher, which indicates obesity, or a BMI of 27 or higher if other weight-related health issues exist.
Oral semaglutide works by lowering appetite and slowing digestion, making it easier for people to stick to lower-calorie diets. When a healthcare provider prescribes it, they often monitor weight, eating habits, and progress closely.
Oral semaglutide is FDA-approved for people with type 2 diabetes, but it has also shown promise in those with obesity, even without diabetes. It helps lower blood sugar and can reduce the risk of diabetes complications in people with both diabetes and excess weight.
In people with type 2 diabetes:
In people with obesity but not diabetes:
Individuals with health risks related to excess weight may also benefit from oral semaglutide. These include people with high blood pressure, high cholesterol, heart disease, or sleep apnea.
Benefits for people with comorbidities:
Doctors look at the whole health picture, not just weight or diabetes status. They consider if complications, such as fatty liver disease or a history of heart disease, are present. A careful health review helps decide if oral semaglutide is a good fit, as not everyone is an ideal candidate. People taking the medication usually need regular check-ins to track side effects and progress.
Oral semaglutide can help with weight loss, but users should be aware of potential side effects and risks before starting. Understanding what to expect may help people make safer choices and better manage symptoms if they happen.
The most reported side effects of oral semaglutide are related to the digestive system. These include nausea, vomiting, diarrhea, constipation, belching, and heartburn. Nausea is the most common and may start soon after treatment begins, especially at higher doses.
Mild stomach upset often improves with time. Some people also report headaches. Digestive side effects like diarrhea or constipation can last for several days or weeks, but they are usually mild to moderate in most users.
Taking oral semaglutide with food or at different times of the day, as advised by a doctor, can sometimes lessen stomach issues. Most people who experience side effects find them manageable, but a few may need to stop the medication if symptoms do not go away. Oral administration must be carefully managed to avoid gastrointestinal adverse reactions.
Although uncommon, oral semaglutide can cause some serious health problems. One of the rare but serious risks is pancreatitis (inflammation of the pancreas), which may lead to severe stomach pain, fever, or vomiting that does not go away.
Gallbladder problems may also develop, and symptoms can include sudden pain in the upper stomach, fever, yellowing of the skin or eyes, and dark urine. The risk for kidney failure may increase if dehydration happens due to vomiting or diarrhea. Patients with a history of kidney disease, acute kidney injury, or chronic kidney disease should consult a healthcare professional to assess risks. Other potential risks, such as thyroid cancer or thyroid tumors, must also be considered based on each person’s medical history.
Allergic reactions, such as a rash, swelling of the face, lips, tongue, or throat, and difficulty breathing, are rare but serious. People with type 2 diabetes using semaglutide may also experience hypoglycemia (low blood sugar), especially if combined with other diabetes drugs.
Staying hydrated, eating small meals, and avoiding spicy or fatty foods can help manage digestive side effects like nausea, vomiting, or diarrhea. Some people find that taking their tablets at the same time each day, following their doctor’s instructions, is helpful.
If vomiting, diarrhea, or stomach pain are severe or continue for several days, people should speak to their healthcare provider. It is important to watch for signs of severe side effects such as ongoing pain, fever, yellow eyes, or trouble breathing.
Doctors usually start patients on a lower dose to help minimize side effects and increase the dose slowly. Patients should report any unusual symptoms right away and not ignore severe or persistent issues.
Taking oral semaglutide for weight management is most effective when combined with healthy habits and professional guidance. Sticking to a daily routine and making small lifestyle changes can help boost results.
Oral semaglutide is designed to work best with a healthy eating plan and regular exercise. People are encouraged to focus on balanced meals, eating more fruits, vegetables, lean proteins, and whole grains. It helps to avoid sugary drinks, fast food, and snacks that are high in fat or sugar.
Exercise is also important. Just 30 minutes of walking or other moderate activity each day can make a difference. Staying active helps the medication work better and supports overall health.
A healthcare provider plays a key role in adjusting and monitoring the oral semaglutide dose. Most people start with a low dose, such as 3 mg once-daily, and the doctor can increase it if needed. This helps the body adjust to the medicine and reduces the chance of side effects.
Doctors also track weight, blood sugar, and any side effects. It is important to keep regular appointments and be honest about any problems or questions. Dose adjustments may happen about every 30 days, depending on how someone responds to the medicine.
If a person misses a dose or feels unwell, they should contact their provider. Taking the medicine at the same time every day, with a sip of plain water and waiting at least 30 minutes before eating or drinking, can maximize absorption.
Combining oral semaglutide with lifestyle support offers the best chance for weight loss. Lifestyle intervention means changing daily habits in small steps. Joining a support group or working with a dietitian or counselor can make these changes easier.
People often benefit from tools like food diaries, step counters, or tracking apps. These help keep goals realistic and progress visible. Support from family, friends, or a community group can make a big difference.
Managing stress and getting enough sleep are also key. Good sleep and self-care help control hunger and boost energy for activity. With the right support, sticking to habits like healthy eating and daily movement becomes easier over time.
Oral semaglutide can help people lose weight, even if they do not have diabetes. Higher doses are linked to greater weight loss results. In some cases, people saw a significant reduction in body weight when they took it regularly, as shown in recent clinical studies.
Doctors usually start with a low dose to help the body adjust. The dose is often increased slowly based on how the person responds. Higher doses are more likely to lead to noticeable weight loss.
Injectable forms like Ozempic medication usually produce slightly more weight loss than oral versions. For example, in one study, people lost about 9.9 pounds with injectable semaglutide and about 8.2 pounds with oral semaglutide over 30 days.
Common side effects include nausea, vomiting, and stomach pain. Some people may also experience diarrhea or constipation. These effects are usually mild and tend to get better as the body gets used to the medicine.
Many people start to see weight loss within a few weeks of beginning oral semaglutide, especially if they are also making healthy changes in their diet and exercise routines. The most noticeable weight changes usually appear within the first few months of treatment.
Oral semaglutide treatment has shown meaningful results in clinical diabetes care, especially for diabetic patients working toward significant weight loss. Its impact on appetite suppression, food cravings, and appetite control supports better body composition and lean muscle mass retention during weight loss. By slowing gastric emptying and enhancing insulin sensitivity and glucose metabolism, oral tablets help regulate high blood sugar while improving glycemic control. When paired with a healthy diet and a personalized weight management plan, patients may experience significant weight reduction and successfully maintain weight loss over time.
In some cases, oral medications may interact with other oral medicines or other oral medications, leading to side effects or reduced effectiveness. Missed dose instructions should always be followed precisely, and adjustments to the maintenance dose may be necessary to ensure consistent patient outcomes.
For those seeking to manage weight effectively, especially with support from healthcare professionals, oral semaglutide offers a valuable option alongside traditional strategies like reduced food intake, exercise, and consistent use of oral medicines. Overall, this medication is a promising advancement for those committed to a structured weight loss journey.
Please note that this article is intended for informational purposes only and should not be construed as medical advice. Before making any changes to your treatments, please consult with your healthcare provider to discuss the appropriateness and safety of such changes.
Are you located in one of these Orange County (OC) / Southern California cities?
Aliso Viejo, Anaheim, Brea, Buena Park, Costa Mesa, Coto de Caza, Cypress, Dana Point, Fountain Valley, Fullerton, Garden Grove, Huntington Beach, Irvine, La Habra, La Palma, Laguna Beach, Laguna Hills, Laguna Niguel, Laguna Woods, Ladera Ranch, Lake Forest, Los Alamitos, Mission Viejo, Newport Beach, Orange, Placentia, Rancho Santa Margarita, San Clemente, San Juan Capistrano, Santa Ana, Seal Beach, Stanton, Tustin, Villa Park, Westminster, or Yorba Linda?
Plastic Surgeon Dr. Brandon Richland, MD and our Cosmetic Aesthetics Team are ready to help you look and feel your absolute best.
Elevate your confidence and self esteem levels to unfathomable new heights!
Schedule your in-person consultation in our modern and luxurious offices in either Fountain Valley, CA (Main HQ) or our Newport Beach, CA office.
Do you live outside of Southern California or short on time? For your convenience, Virtual Consultations are also available.
Our warm and engaging Team of carefully selected Aesthetics Professionals will make you feel calm, cool, collected, and right at home throughout your entire consultation and surgery process.
Schedule Your Aesthetics Consultation here, or call us directly at 949-867-4496 today.
Dr. Brandon Richland, MD is a respected Board Certified Licensed Plastic Surgeon in Orange County / Southern California specializing in cosmetic and reconstructive surgeries.
Driven by his passion for medicine, Dr. Richland obtained his Doctor of Medicine (M.D.) degree from the prestigious program at Saint Louis University (SLU) School of Medicine in 2013. His exceptional skills were recognized when he received the McGraw Hill / Lange Medical Student Academic Achievement Award, and graduated top of his class with Honors. For his undergraduate degree, he attended University of California, Los Angeles (UCLA) and graduated with Honors in 2009.
To further enhance his surgical expertise, Dr. Richland completed his Residency in Plastic Surgery at the University of California, Irvine (UCI) from 2013 to 2019 earning the Academic Achievement Award twice during this period. A total of 14 years in dedicated schooling and medical residency.
Dr. Richland is actively involved with healthcare and medical societies, as a Diplomate of the American Board of Plastic Surgery, a member of the American Society of Plastic Surgeons, American Society of Aesthetic Plastic Surgeons, and the California Society of Plastic Surgeons.
Contact Dr. Richland today by visiting RichlandMD.com, scheduling a cosmetic consultation, or by calling 949-867-4496 directly.
Cover Image Credit: Kenishirotie / 123RF.com (Licensed). Photo Illustration by: Dr. Brandon Richland, MD.